Pharmacy Medical News about bromfenac

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ophthalmic utility of topical bromfenac, a twice-daily nonsteroidal anti-inflammatory agent
Expert Opinion in Pharmacotherapy, 10/19/09

Jones J et al. – The comfort and reduced frequency of use offered by bromfenac would be expected to improve patient compliance, which would in turn be expected to result in adoption of bromfenac over other NSAIDs by many physicians. However, head–to–head trials comparing bromfenac with other NSAIDs using a twice–daily dosing schedule have not been undertaken. Bromfenac and other NSAIDs are seeing expanded use for the treatment and prevention of cystoid macular edema, and could have clinical utility in other diseases of vascular permeability.

<< Previous
The clinical efficacy and abuse potential of combination...

Next >>
Pediatric Adverse Drug Events in the Outpatient Setting: An...